Brought to you by:
CVRx announces new CPT Category I codes for Barostim baroreflex activation therapy
CVRx, the company behind the Barostim baroreflex activation therapy system, recently announced that the American Medical Association (AMA) has accepted new Current Procedural Terminology (CPT) Category I codes for the device, which treats the symptoms of heart failure. The decision…
Need for ‘clear, well-defined guidelines’ in patient selection for surgical implantation of baroreflex activation therapy devices identified
The emergence of a baroreflex activation therapy device for heart failure patients is drawing in the assistance of the open surgical expertise of vascular surgeons in the arena of the carotid bulb— and drawing attention to a need for “clear…